Parterships

• The licensing of high quality biology-led research programmes from key European academic institutions.

• The creation of a flexible partnership with the academic and Technology Transfer teams with a shared risk approach.

• The development of programmes to the point where they can be successfully marketed to industry by focussing on the critical jump from biological research (targets) to chemistry (compounds).

• The creation of revenue, wherein University originators retain a share of the down-stream value (royalties).